News Image

For those who appreciate growth without the sticker shock, NASDAQ:CORT is worth considering.

By Mill Chart

Last update: Aug 27, 2024

CORCEPT THERAPEUTICS INC (NASDAQ:CORT) has caught the eye of our stock screener as an affordable growth stock. NASDAQ:CORT is displaying robust growth metrics and also excels in terms of profitability, solvency, and liquidity. Additionally, it appears to be reasonably priced. Let's delve into the details.


Affordable growth stocks image

How We Gauge Growth for NASDAQ:CORT

ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:CORT, the assigned 8 reflects its growth potential:

  • The Earnings Per Share has grown by an impressive 36.14% over the past year.
  • CORT shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.02%.
  • CORT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.94% yearly.
  • The Earnings Per Share is expected to grow by 26.44% on average over the next years. This is a very strong growth
  • CORT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.69% yearly.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Valuation Examination for NASDAQ:CORT

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:CORT has achieved a 6 out of 10:

  • 82.29% of the companies in the same industry are more expensive than CORT, based on the Price/Earnings ratio.
  • 78.13% of the companies in the same industry are more expensive than CORT, based on the Price/Forward Earnings ratio.
  • CORT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CORT is cheaper than 79.69% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CORT is valued cheaper than 82.81% of the companies in the same industry.
  • The excellent profitability rating of CORT may justify a higher PE ratio.
  • CORT's earnings are expected to grow with 52.60% in the coming years. This may justify a more expensive valuation.

A Closer Look at Health for NASDAQ:CORT

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:CORT, the assigned 9 for health provides valuable insights:

  • CORT has an Altman-Z score of 21.55. This indicates that CORT is financially healthy and has little risk of bankruptcy at the moment.
  • CORT has a Altman-Z score of 21.55. This is amongst the best in the industry. CORT outperforms 91.15% of its industry peers.
  • CORT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • CORT has a Current Ratio of 5.57. This indicates that CORT is financially healthy and has no problem in meeting its short term obligations.
  • CORT has a Current ratio of 5.57. This is in the better half of the industry: CORT outperforms 66.15% of its industry peers.
  • CORT has a Quick Ratio of 5.48. This indicates that CORT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 5.48, CORT is in the better half of the industry, outperforming 66.67% of the companies in the same industry.

Profitability Assessment of NASDAQ:CORT

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:CORT, the assigned 8 is noteworthy for profitability:

  • CORT has a Return On Assets of 17.63%. This is amongst the best in the industry. CORT outperforms 97.40% of its industry peers.
  • Looking at the Return On Equity, with a value of 21.13%, CORT belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
  • CORT has a better Return On Invested Capital (17.98%) than 94.27% of its industry peers.
  • CORT had an Average Return On Invested Capital over the past 3 years of 21.81%. This is above the industry average of 18.11%.
  • CORT has a Profit Margin of 22.12%. This is amongst the best in the industry. CORT outperforms 94.27% of its industry peers.
  • CORT has a better Operating Margin (22.46%) than 89.06% of its industry peers.
  • CORT has a better Gross Margin (98.50%) than 97.92% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Check the latest full fundamental report of CORT for a complete fundamental analysis.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (12/20/2024, 8:03:39 PM)

After market: 52.55 +1.15 (+2.24%)

51.4

+0.25 (+0.49%)

Follow us for more